A New Modality in Dyslipidemia Treatment: Antisense Oligonucleotide Therapy.

Kim, Kyuho; Choi, Sung Hee

Kim, Kyuho; Choi, Sung Hee.

Affiliation

Kim K; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Choi SH; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

J Lipid Atheroscler ; 11(3): 250-261, 2022 Sep.

Article in En | MEDLINE | ID: mdl-36212748

Key words

Angiopoietin-like protein 3; Antisense oligonucleotides; Apolipoprotein C-III; Apolipoprotein(a); Dyslipidemia

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515732
https://dx.doi.org/10.12997/jla.2022.11.3.250

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Lipid Atheroscler Year: 2022 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515732
https://dx.doi.org/10.12997/jla.2022.11.3.250

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Lipid Atheroscler Year: 2022 Document type: Article